Cargando…

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Detalles Bibliográficos
Autores principales:	Altman, Raul, Luciardi, Héctor L, Muntaner, Juan, Herrera, Ramón N
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC331420/ https://www.ncbi.nlm.nih.gov/pubmed/14723795 http://dx.doi.org/10.1186/1477-9560-2-1

Ejemplares similares

Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice
por: Sabir, Ian N, et al.
Publicado: (2013)

Aspirin Resistance
por: Mansour, Khaled, et al.
Publicado: (2009)

Antithrombotic therapy after mitral valve repair: VKA or aspirin?
por: van der Wall, Sake J., et al.
Publicado: (2018)

The implications of aspirin resistance in renal failure
por: Thachil, Jecko
Publicado: (2008)

Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Preeclampsia and aspirin
por: Ahn, Tae Gyu, et al.
Publicado: (2023)

Aspirin-Exacerbated Asthma
por: Varghese, Mathew, et al.
Publicado: (2008)

Aspirin and multiple sclerosis
por: Tsau, Sheila, et al.
Publicado: (2015)

High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023)

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
por: Angiolillo, Dominick J., et al.
Publicado: (2022)

Aspirin for primary prevention of cardiovascular disease
por: Nansseu, Jobert Richie N., et al.
Publicado: (2015)

The Metabolites of the Dietary Flavonoid Quercetin Possess Potent Antithrombotic Activity, and Interact with Aspirin to Enhance Antiplatelet Effects
por: Stainer, Alexander R., et al.
Publicado: (2019)

Use of Cerebrolysin in combination with high‐dose aspirin antithrombotic treatment of ischemic stroke: A case report
por: Borisevich, Alexander, et al.
Publicado: (2021)

Full versus Baby Dose Aspirin for Antithrombotic Prophylaxis in Free Tissue Transfer: Does Size Matter?
por: Karamanos, Efstathios, et al.
Publicado: (2022)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

The role of aspirin in women’s health
por: Verheugt, Freek WA, et al.
Publicado: (2011)

Is Aspirin Dangerous
Publicado: (1918)

Author’s reply: Predictors of aspirin resistance
por: Toptas, Tayfur, et al.
Publicado: (2014)

Aspirin: the miracle drug?
por: Thota, Prashanthi N.
Publicado: (2018)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Molecular targets of aspirin and cancer prevention
por: Alfonso, L, et al.
Publicado: (2014)

Aspirin: Pharmacology and Clinical Applications
por: Paez Espinosa, Enma V., et al.
Publicado: (2012)

Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010)

Fifty years with aspirin and platelets
por: Patrono, Carlo
Publicado: (2022)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
por: Mastalerz, Lucyna, et al.
Publicado: (2021)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

Alleviating Aspirin-Induced Gastric Injury by Binding Aspirin to β-Lactoglobulin
por: Chen, Jin, et al.
Publicado: (2022)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)

Critical Overview on the Benefits and Harms of Aspirin
por: Kwok, Chun Shing, et al.
Publicado: (2010)

Aspirin for Primary Prevention of Cardiovascular Disease
por: Kim, Ji Hye, et al.
Publicado: (2019)

Aspirin and Infection: A Narrative Review
por: Di Bella, Stefano, et al.
Publicado: (2022)

Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers
por: Elwood, Peter C, et al.
Publicado: (2021)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Ryan, Lindsey, et al.
Publicado: (2020)

Improving the Gastrointestinal Tolerability of Aspirin in Older People
por: Newton, Julia L
Publicado: (2006)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t37phhanvspgko4648b30u468g